The Use of Zostavax in Spain: the Economic Case for Vaccination of Individuals Aged 50 Years and Older.
Journal of Medical Economics（2016）
Key words
Cost-effectiveness,Spain,VZV,Zostavax,50 years,Vaccination
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined